
|Poll|August 22, 2019
Poll: Is DRE still a relevant tool in the management of prostate cancer?
Do you feel that DRE is still a relevant tool in the management of prostate cancer? Take our latest poll and let us know.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
TULSA preserves penile length vs robotic prostatectomy in CAPTAIN trial
2
KEYNOTE-B15 data on enfortumab vedotin plus pembrolizumab in MIBC published in NEJM
3
FDA grants priority review to talazoparib plus enzalutamide for HRR gene-altered mCSPC
4
The UroOnc Minute: Optimizing Patient Follow-Up in Urologic Oncology, With Jason Hafron, MD
5











